#sbdd
Need #apphysics help? Look no further at my videos!

www.youtube.com/watch?v=sBDD...
RIGHT HAND RULE #apphysics
YouTube video by FeministScience
www.youtube.com
November 12, 2026 at 12:29 AM
#PostDoc opportunity: machine learning in structure-based #DrugDesign at Uppsala University (Sweden) start: 01-Jan-2027 | duration: 2 years | closing: 23-Nov-2026 #ML #SBDD #CompChem #cheminformatics #chemsky 🧪
uu.varbi.com/en/what:job/...
Postdoctoral position in structure-based drug design using machine learning
Are you interested in developing virtual screening techniques to discover novel drugs? We welcome you to apply for a postdoctoral position in the international and scientifically excellent research en
uu.varbi.com
November 10, 2026 at 7:30 AM
Een teken van leven van mijn oude werk bij de Stralingsbeschermingsdienst van Defensie (SBDD): inclusief ons alarmnummer in geval van een stralingsincident #tritium #H3
October 3, 2026 at 1:03 PM
SBDD

same brain, different day.

😱😂
September 15, 2026 at 7:00 AM
What's the future of structural biology look like? Our very own reciprocal astronaut @alisiafadini.bsky.social recently joined Jay Chodaparambil, Melanie Adams-Cioaba, Robin Roehm and @dereklowe.bsky.social for a panel on the future of SBDD in Boston at #IBA2026 to discuss exactly that!
May 13, 2026 at 5:28 PM
probability path, we propose VLB-Optimal Scheduling (VOS) strategy in this under-explored area, which optimizes VLB as a path integral for SBDD. Our model effectively enhances molecular geometries and interaction modeling, achieving state-of-the-art [3/4 of https://arxiv.org/abs/2505.07286v1]
May 13, 2025 at 6:14 AM
arXiv:2505.07286v1 Announce Type: new
Abstract: Structure-Based Drug Design (SBDD) is crucial for identifying bioactive molecules. Recent deep generative models are faced with challenges in geometric structure modeling. A major bottleneck lies in the [1/4 of https://arxiv.org/abs/2505.07286v1]
May 13, 2025 at 6:14 AM
states provide superior inputs for traditional SBDD approaches, playing a significant role in practical drug discovery. [6/6 of https://arxiv.org/abs/2503.03989v1]
March 7, 2025 at 6:17 AM
transition rate is dictated by the intrinsic energy barrier between them, making the sampling process computationally expensive. To overcome the aforementioned challenges, we propose to use generative modeling for SBDD considering [3/6 of https://arxiv.org/abs/2503.03989v1]
March 7, 2025 at 6:17 AM
arXiv:2503.03989v1 Announce Type: new
Abstract: The dynamic nature of proteins, influenced by ligand interactions, is essential for comprehending protein function and progressing drug discovery. Traditional structure-based drug design (SBDD) [1/6 of https://arxiv.org/abs/2503.03989v1]
March 7, 2025 at 6:16 AM
combines the structural precision of 3D-SBDD models with the chemical reasoning capabilities of large language models (LLMs). CIDD begins by generating supporting molecules with 3D-SBDD models and then refines these [4/7 of https://arxiv.org/abs/2503.01376v1]
March 4, 2025 at 6:17 AM
advancements in improving docking scores, advanced 3D-SBDD generative models still face challenges in producing drug-like candidates that meet medicinal chemistry standards and pharmacokinetic requirements. These limitations [2/7 of https://arxiv.org/abs/2503.01376v1]
March 4, 2025 at 6:17 AM
arXiv:2503.01376v1 Announce Type: new
Abstract: Structure-Based Drug Design (SBDD) has revolutionized drug discovery by enabling the rational design of molecules for specific protein targets. Despite significant [1/7 of https://arxiv.org/abs/2503.01376v1]
March 4, 2025 at 6:16 AM
Key takeaway: ligand strain is not just a fixed molecular descriptor. It depends on the bound pose, binding pocket, charge, flexibility. That matters for pose assessment, lead optimization, selectivity design, and docking/free-energy workflows. #SBDD #CompChem #chemsky chemrxiv.org/doi/abs/10.2...
Efficient and Accurate Ligand Strain Calculations in Solution with the AIMNet2 Neural Network Potential | ChemRxiv
Conformational strain, the energy a ligand pays to adopt its bound conformation, contributes to binding affinity but is routinely misestimated. The standard estimate references a single gasphase energ...
chemrxiv.org
July 23, 2026 at 9:56 AM
March 9, 2026 at 12:56 AM
Oops forgot some tags #cryoem #sbdd #crystallography
January 9, 2026 at 6:32 PM
Great review on SBDD:
February 4, 2026 at 2:12 PM
Hello everyone, I am looking for my next role in the computational chemistry/biophysics space 🛫

I have 12 years of research experience in protein simulations/SBDD, looking for national lab/industry scientist positions anywhere in the world. Any connections/leads welcomed - thanks in advance! 🙏🏻
March 5, 2026 at 8:59 PM
Anyone knows of any opensource/free tool for conformer generation faster than rdkit? And any more accurate? Or BOTH?!?!?! 🥲 #compchem #chemsky #sbdd
April 24, 2025 at 1:43 PM
✨ We’ll be at the Structure-Based Drug Design Summit in Boston this week, showcasing recent #CryoSPARC developments for industrial applications in #cryoEM and #SBDD.

If you're attending, we'd love to connect! structure-based-drug-design-summit.com
July 27, 2026 at 12:54 PM
🚀 Can automation scale #cryoEM?
We recently demonstrated it is possible to make #cryo-EM more routine and scalable testing across 21 challenging #GPCR datasets, a real-world scenario for #SBDD, achieving results equal or better than manual processing.
Read more 👉 cryosparc.com/blog/automat...
CryoSPARC | Automated Workflows in CryoSPARC™
How to make use of one-click, automated data processing workflows that can provide equal or better results as manual processing
cryosparc.com
June 25, 2026 at 12:00 PM
In a recent #NatComm study, researchers leveraged high-resolution #cryoEM structures of the κ-opioid receptor bound to difelikefalin to guide the design of a more selective compound with reduced side-effect potential. 👉 cryosparc.com/blog/kor-sbdd

#StructuralBiology #SBDD #CryoSPARC
CryoSPARC | Scratching Beneath the Surface: Cryo-EM Guides New Opioid Drug Design
Cryo-EM revealed the molecular basis of KOR signaling bias, enabling structure-based drug design of an anti-pruritic peptide with reduced side effects.
cryosparc.com
June 16, 2026 at 11:57 AM
We will be at the @proterosma.bsky.social IBA Conference in Boston next week! Stop by our poster to chat about the latest developments in #CryoSPARC, including new results from fully automated data processing for #sbdd repeat-target scenarios & v5 features 🔬 
bit.ly/49hQoKo
#SingleParticle #Cryo-EM
May 7, 2026 at 3:35 PM
On the SBDD point, the constraint I keep running into is holdout behaviour. Accuracy on complexes with a close homolog in training looks very different from accuracy without one, and for a genuinely novel target that gap is the whole question. Did the local run give you a way to probe it?
August 2, 2026 at 1:52 PM